ELTX Elicio Therapeutics, Inc.

Fundamentals / CIK 0001601485 / USD

Elicio Therapeutics, Inc. reported $39.60M in total assets and a net loss of $35.74M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ELTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$36.36M$18.18M$0-$77.31MFY 2020 Revenue: $2.88MFY 2020 Net Income: -$80.11M2020FY 2021 Revenue: $28.31MFY 2021 Net Income: -$54.57M2021FY 2022 Revenue: $2.30MFY 2022 Net Income: -$28.21M2022FY 2023 Net Income: -$35.20M2023FY 2024 Net Income: -$51.90M2024FY 2025 Net Income: -$39.57M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $2.30M $28.31M $2.88M
Cost of Revenue -- -- -- $0 $433K $1.19M
Gross Profit -- -- -- $2.30M $27.88M $1.69M
Research & Development $24.90M $33.66M $23.85M $18.10M $48.70M $38.98M
Operating Income -$37.71M -$44.99M -$35.74M -$23.73M -$39.31M -$55.27M
EBITDA -$37.51M -$44.66M -$35.36M -$23.34M -$39.22M -$55.17M
Interest Expense $1.13M $455K $1.06M $3.60M -- --
Income Before Tax -$39.57M -$51.90M -- -$38.80M -$54.57M -$80.11M
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$39.57M -$51.90M -$35.20M -$28.21M -$54.57M -$80.11M
Basic EPS -$2.58 -$4.25 -$6.96 -$188.89 -$4.08 -$11.49
Diluted EPS -$2.58 -$4.25 -$6.96 -$188.89 -$4.08 -$11.49
Basic Shares Outstanding 15.3M 12.2M 5.1M 149.3K 13.3M 7.0M
Diluted Shares Outstanding 15.3M 12.2M 5.1M 149.3K 13.3M 7.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $4.89M $6.81M $6.76M $5.08M $5.04M $7.01M $7.78M $10.71M
Operating Income -$8.45M -$10.43M -$10.60M -$8.84M -$8.04M -$10.09M -$10.74M -$13.48M
EBITDA -$8.45M -$10.33M -$10.56M -$8.79M -$7.95M -$9.99M -$10.68M -$13.39M
Interest Income $237K $138K $157K -- $199K $168K $210K --
Interest Expense $413K $410K $407K $337K $426K $194K $176K $234K
Income Before Tax -$7.92M -- -- -- -$10.08M -- -- --
Income Tax Expense $55K $0 $0 $0 $0 $0 $0 $0
Net Income -$7.98M -$8.22M -$11.82M -$7.72M -$10.08M -$10.56M -$11.21M -$14.00M
Basic EPS -$0.30 -$0.43 -$0.65 -- -$0.60 -$0.66 -$0.87 --
Diluted EPS -$0.30 -$0.43 -$0.65 -- -$0.60 -$0.66 -$0.87 --
Basic Shares Outstanding 26.3M 19.2M 18.2M -- 16.7M 16.1M 13.0M --
Diluted Shares Outstanding 26.3M 19.2M 18.2M -- 16.7M 16.1M 13.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $18.56M $17.62M $12.89M $6.16M $88.76M $34.61M
Cash & Short-Term Investments $18.56M $17.62M $12.89M $6.16M $88.76M $34.61M
Accounts Receivable, Net -- -- -- $0 -- --
Other Current Assets -- -- -- $246K $498K $360K
Total Current Assets $19.31M $20.69M $16.35M $10.72M $91.25M $42.30M
Property, Plant & Equipment, Net $295K $483K $717K $1.15M $451K $156K
Other Non-Current Assets -- -- -- $61K $106K $0
Total Non-Current Assets $6.55M $7.49M $10.80M $11.95M $5.27M $5.05M
Total Assets $25.86M $28.18M $27.15M $22.66M $96.51M $47.35M
Accounts Payable $672K $1.04M $4.37M $2.81M $4.71M $5.58M
Short-Term Debt $0 -- -- -- -- --
Deferred Revenue (Current) $0 $1.17M $694K $1.44M $2.30M $3.94M
Total Current Liabilities $8.11M $11.52M $9.76M $6.87M $11.30M $107.4M
Long-Term Debt $9.41M $20.03M -- -- $0 $635K
Deferred Revenue (Non-Current) -- -- -- -- $0 $25.86M
Other Non-Current Liabilities -- -- -- -- $0 --
Total Non-Current Liabilities $16.12M $27.97M $6.02M $6.88M $3.71M $30.35M
Total Liabilities $24.23M $39.49M $15.77M $13.75M $15.01M $137.8M
Total Debt (incl. Leases) $14.51M $26.04M $6.92M $3.71M $4.66M $5.09M
Common Stock $178K $110K $96K $3.0K $300K $156K
Retained Earnings -$233.7M -$194.1M -$142.2M -$107.0M -$215.1M -$160.6M
Accumulated Other Comp. Income -$127K -$175K -$197K $0 -$103K -$333K
Total Stockholders' Equity $1.64M -$11.31M $11.37M -$102.1M -$74.54M -$90.45M
Total Equity $1.64M -$11.31M $11.37M -$102.1M -$74.54M -$90.45M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $30.90M $23.48M $14.95M $18.56M $20.61M $22.09M $18.35M $17.62M
Cash & Short-Term Investments $30.90M $23.48M $14.95M $18.56M $20.61M $22.09M $18.35M $17.62M
Total Current Assets $34.03M $25.48M $16.20M $19.31M $21.46M $22.60M $20.93M $20.69M
Property, Plant & Equipment, Net $182K $213K $249K $295K $328K $377K $430K $483K
Total Non-Current Assets $5.56M $5.84M $6.49M $6.55M $6.82M $6.93M $7.21M $7.49M
Total Assets $39.60M $31.33M $22.69M $25.86M $28.28M $29.53M $28.14M $28.18M
Accounts Payable $379K $839K $272K $672K $321K $3.87M $4.04M $1.04M
Short-Term Debt $2.48M -- -- $0 -- -- -- --
Deferred Revenue (Current) -- -- -- $0 $0 $0 $680K $1.17M
Total Current Liabilities $9.93M $9.20M $7.23M $8.11M $6.51M $9.92M $11.41M $11.52M
Long-Term Debt $7.16M $9.54M $9.47M $9.41M $9.72M $9.34M -- $20.03M
Total Non-Current Liabilities $10.81M $14.19M $16.90M $16.12M $17.95M $17.77M $7.83M $27.97M
Total Liabilities $20.75M $23.39M $24.13M $24.23M $24.47M $27.69M $19.24M $39.49M
Total Debt (incl. Leases) $13.99M $14.15M $14.34M $14.51M $15.06M $14.90M $5.79M $26.04M
Common Stock $283K $219K $186K $178K $173K $163K $160K $110K
Retained Earnings -$261.7M -$253.7M -$245.5M -$233.7M -$226.0M -$215.9M -$205.3M -$194.1M
Accumulated Other Comp. Income -$127K -$126K -$122K -$127K -$31K -$70K -$144K -$175K
Total Stockholders' Equity $18.85M $7.94M -$1.44M $1.64M $3.82M $1.83M $8.90M -$11.31M
Total Equity $18.85M $7.94M -$1.44M $1.64M $3.82M $1.83M $8.90M -$11.31M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$39.57M -$51.90M -$35.20M -$28.21M -$54.57M -$80.11M
Depreciation & Amortization $204K $321K $382K $390K $91K $98K
Stock-Based Compensation $2.70M $1.45M $1.18M $579K $12.04M $4.72M
Change in Payables -$366K -$3.33M $23K $1.12M -$866K -$5.61M
Operating Cash Flow -$36.95M -$37.07M -$32.69M -$22.18M -$52.64M -$22.89M
Capital Expenditure -$16K -$87K -$66K -$654K -$382K -$41K
Free Cash Flow -$36.97M -$37.16M -$32.76M -$22.83M -$53.02M -$22.93M
Investing Cash Flow -$16K -$84K -$32K -$654K -$382K -$41K
Common Stock Issued $16.24M $4.55M $7.00M $0 $107.5M -$522K
Share Repurchases -- $0 -$150K $0 -- --
Financing Cash Flow $36.70M $42.32M $38.61M $21.20M $107.2M $52.41M
Net Change in Cash -$225K $5.19M $5.89M -$1.63M $54.15M $29.04M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.98M -$8.22M -$11.82M -$7.72M -$10.08M -$10.56M -$11.21M -$14.00M
Depreciation & Amortization $0 $100K $46K $49K $100K $100K $53K $85K
Stock-Based Compensation $1.11M $935K $868K $772K $698K $710K $517K $464K
Change in Payables -$460K $627K -$460K $351K -$3.54M -$172K $3.00M -$946K
Operating Cash Flow -$10.36M -$8.16M -$11.64M -$6.80M -$11.09M -$8.95M -$10.12M -$8.74M
Capital Expenditure -- -- -- -- -- -- -- -$45K
Free Cash Flow -- -- -- -- -- -- -- -$8.79M
Investing Cash Flow -- -- -- -$16K $0 $0 $0 -$45K
Common Stock Issued -- -- -- $16.24M -$2.85M $2.02M $835K -$858K
Financing Cash Flow $17.79M $16.51M $8.03M $4.86M $9.57M $11.93M $10.33M $227K
Net Change in Cash $7.42M $8.34M -$3.61M -$2.05M -$1.48M $3.06M $240K -$8.54M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- 100.0% 98.5% 58.7%
Operating Margin -- -- -- -1031.4% -138.8% -1919.2%
Net Profit Margin -- -- -- -1225.9% -192.8% -2781.5%
Return on Equity (ROE) -2418.8% -- -309.5% -- -- --
Return on Assets (ROA) -153.0% -184.2% -129.7% -124.5% -56.5% -169.2%
Current Ratio 2.38x 1.80x 1.68x 1.56x 8.08x 0.39x
Quick Ratio 2.29x 1.53x 1.32x 0.90x 7.86x 0.32x
Debt to Equity 8.87x -- 0.61x -- -- --
Revenue Growth (YoY) -- -- -- -91.9% +883.1% --
Gross Profit Growth (YoY) -- -- -- -91.7% +1549.6% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -189.6% -476.8% -- -2418.8% -1201.7% -2977.8% -575.9% --
Return on Assets (ROA) -90.3% -120.8% -177.1% -153.0% -162.1% -184.9% -182.2% -184.2%
Current Ratio 3.43x 2.77x 2.24x 2.38x 3.29x 2.28x 1.83x 1.80x
Quick Ratio 3.11x 2.55x 2.07x 2.29x 3.16x 2.23x 1.61x 1.53x
Debt to Equity 0.74x 1.78x -- 8.87x 3.95x 8.13x 0.65x --
Source: SEC EDGAR CompanyFacts (CIK 0001601485) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal